Abstract
98P Efficacy and safety of durvalumab plus gemcitabine and cisplatin in Chinese participants with advanced biliary tract cancer: Extension cohort of the phase III, randomised, double-blind, placebo-controlled, global TOPAZ-1 study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have